Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Cardiovascular pharmacogenetics.

Myburgh R, Hochfeld WE, Dodgen TM, Ker J, Pepper MS.

Pharmacol Ther. 2012 Mar;133(3):280-90. doi: 10.1016/j.pharmthera.2011.11.002. Epub 2011 Nov 22. Review.

PMID:
22123178
2.

Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.

Nakagawa K, Ishizaki T.

Pharmacol Ther. 2000 Apr;86(1):1-28. Review.

PMID:
10760544
3.

Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.

Terra SG, Johnson JA.

Am J Cardiovasc Drugs. 2002;2(5):287-96. Review.

PMID:
14727958
4.

Pharmacogenetics and cardiovascular disease: impact on drug response and applications to disease management.

Humma LM, Terra SG.

Am J Health Syst Pharm. 2002 Jul 1;59(13):1241-52. Review.

PMID:
12116890
5.

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.

Mango R, Vecchione L, Raso B, Borgiani P, Brunetti E, Mehta JL, Lauro R, Romeo F, Novelli G.

Expert Opin Pharmacother. 2005 Dec;6(15):2565-76. Review.

PMID:
16316297
6.

[Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].

Dzida G.

Kardiol Pol. 2004 Mar;60(3):304-8. Review. Polish. No abstract available.

PMID:
15156230
7.

Pharmacogenetic implications of the eNOS polymorphisms for cardiovascular action drugs.

Silva PS, Lacchini R, Gomes Vde A, Tanus-Santos JE.

Arq Bras Cardiol. 2011 Feb;96(2):e27-34. Review. English, Portuguese, Spanish.

8.

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.

Zaiou M, Benachour H, Marteau JB, Visvikis-Siest S, Siest G.

Curr Pharm Des. 2009;15(27):3193-206. Review.

PMID:
19754391
9.

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.

Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

Eur J Pharmacol. 2005 Dec 19;527(1-3):1-22. Epub 2005 Nov 28. Review.

PMID:
16316654
10.

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C.

Pharmacol Ther. 2007 Dec;116(3):496-526. Epub 2007 Oct 9. Review.

PMID:
18001838
11.

Gender, ethnicity and genetics in cardiovascular disease: part 1: Basic principles.

Schaefer BM, Caracciolo V, Frishman WH, Charney P.

Heart Dis. 2003 Mar-Apr;5(2):129-43. Review.

PMID:
12713680
12.

Cardiovascular drugs and the genetic response.

Dandona S.

Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):13-7. Review.

13.

Pharmacogenetics and cardiovascular disease management.

Weston CF.

Hosp Med. 2004 Oct;65(10):594-8. Review.

PMID:
15524338
14.

Cardiovascular pharmacogenomics.

Johnson JA, Cavallari LH.

Exp Physiol. 2005 May;90(3):283-9. Epub 2005 Mar 18. Review.

15.

Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.

Ginghină C, Stănescu R, Coman IM, Bărbari L, Popescu BA.

Rom J Intern Med. 2007;45(4):313-9. Review.

PMID:
18767405
16.

A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

Verschuren JJ, Trompet S, Wessels JA, Guchelaar HJ, de Maat MP, Simoons ML, Jukema JW.

Eur Heart J. 2012 Jan;33(2):165-75. doi: 10.1093/eurheartj/ehr239. Epub 2011 Jul 30. Review.

PMID:
21804109
17.

[Pharmacogenomics and pharmacoproteomics: a strategy for cardio-vascular drugs].

Siest G, Marteau JB, Maumus S, Berrahmoune H, Jeannesson E, Samara A, Batt AM, Visvikis-Siest S.

Ann Pharm Fr. 2007 May;65(3):203-10. Review. French.

PMID:
17489077
18.

Prospects of personalized medicine in cardiovascular diseases.

Lenfant C.

Metabolism. 2013 Jan;62 Suppl 1:S6-10. doi: 10.1016/j.metabol.2012.08.018. Epub 2012 Sep 21.

PMID:
22999711
19.

A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics.

Franconi F, Carru C, Spoletini I, Malorni W, Vella S, Mercuro G, Deidda M, Rosano G.

Ther Deliv. 2011 Nov;2(11):1437-53. Review.

PMID:
22826875
20.

Advances in the development of genetic markers for the diagnosis of disease and drug response.

Halapi E, Hakonarson H.

Expert Rev Mol Diagn. 2002 Sep;2(5):411-21. Review.

PMID:
12271813

Supplemental Content

Support Center